These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9925295

  • 21. Orally active GPIIb/IIIa antagonists: synthesis and biological activities of masked amidines as prodrugs of 2-[(3S)-4.
    Kitamura S, Fukushi I, Miyawaki T, Kawamura M, Terashita E, Naka T.
    Chem Pharm Bull (Tokyo); 2001 Mar; 49(3):268-77. PubMed ID: 11253915
    [Abstract] [Full Text] [Related]

  • 22. The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action.
    Yang G, Zhu H, Zhao M, Wu J, Wang Y, Wang Y, Zheng M, Chen M, Liu J, Peng S.
    Mol Biosyst; 2012 Oct; 8(10):2672-9. PubMed ID: 22801714
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and properties of peptidomimetics--inhibitors of platelet aggregation.
    Andronati SA, Krysko AA, Kabanov VM, Karaseva TL, Kabanova TA.
    Acta Pol Pharm; 2000 Nov; 57 Suppl():15-21. PubMed ID: 11293251
    [Abstract] [Full Text] [Related]

  • 24. Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonists.
    Askew BC, Bednar RA, Bednar B, Claremon DA, Cook JJ, McIntyre CJ, Hunt CA, Gould RJ, Lynch RJ, Lynch JJ, Gaul SL, Stranieri MT, Sitko GR, Holahan MA, Glass JD, Hamill T, Gorham LM, Prueksaritanont T, Baldwin JJ, Hartman GD.
    J Med Chem; 1997 Jun 06; 40(12):1779-88. PubMed ID: 9191954
    [Abstract] [Full Text] [Related]

  • 25. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
    Mousa SA.
    Curr Pharm Des; 2003 Jun 06; 9(28):2317-22. PubMed ID: 14529393
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Fibrinogen receptor (GPIIb-IIIa) antagonists derived from 5,6-bicyclic templates. Amidinoindoles, amidinoindazoles, and amidinobenzofurans containing the N-alpha-sulfonamide carboxylic acid function as potent platelet aggregation inhibitors.
    Su T, Naughton MA, Smyth MS, Rose JW, Arfsten AE, McCowan JR, Jakubowski JA, Wyss VL, Ruterbories KJ, Sall DJ, Scarborough RM.
    J Med Chem; 1997 Dec 19; 40(26):4308-18. PubMed ID: 9435900
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Platelet glycoprotein IIb/IIIa receptor antagonists derived from isoxazolidines.
    Confalone PN, Jin F, Mousa SA.
    Bioorg Med Chem Lett; 1999 Jan 04; 9(1):55-8. PubMed ID: 9990456
    [Abstract] [Full Text] [Related]

  • 31. Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3.
    Mousa SA, Bozarth JM, Lorelli W, Forsythe MS, Thoolen MJ, Slee AM, Reilly TM, Friedman PA.
    J Pharmacol Exp Ther; 1998 Sep 04; 286(3):1277-84. PubMed ID: 9732389
    [Abstract] [Full Text] [Related]

  • 32. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
    Huang TF, Chang CH, Ho PL, Chung CH.
    Exp Hematol; 2008 Dec 04; 36(12):1704-13. PubMed ID: 18809237
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparative studies of a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, and abciximab on in vitro antiplatelet effect and binding properties.
    Suzuki K, Sato K, Kamohara M, Kaku S, Kawasaki T, Yano S, Iizumi Y.
    Biol Pharm Bull; 2002 Aug 04; 25(8):1006-12. PubMed ID: 12186399
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Three-dimensional quantitative structure-activity relationship analyses of RGD mimetics as fibrinogen receptor antagonists.
    Miyashita M, Akamatsu M, Hayashi Y, Ueno T.
    Bioorg Med Chem Lett; 2000 May 01; 10(9):859-63. PubMed ID: 10853647
    [Abstract] [Full Text] [Related]

  • 38. A novel anti-platelet peptide (Z4A5) potential for glycoprotein IIb/IIIa inhibits platelet aggregation.
    Li YX, Sun Q, Zhang H, Ren ST, Liao YR, Wang Y, Shen XL, Wang B.
    Thromb Res; 2012 May 01; 129(5):e217-22. PubMed ID: 22445430
    [Abstract] [Full Text] [Related]

  • 39. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA, Bozarth JM, Forsythe MS, Jackson SM, Leamy A, Diemer MM, Kapil RP, Knabb RM, Mayo MC, Pierce SK.
    Circulation; 1994 Jan 01; 89(1):3-12. PubMed ID: 8281661
    [Abstract] [Full Text] [Related]

  • 40. Potent dibasic GPIIb/IIIa antagonists with reduced prolongation of bleeding time: synthesis and pharmacological evaluation of 2-oxopiperazine derivatives.
    Kitamura S, Fukushi H, Miyawaki T, Kawamura M, Konishi N, Terashita Z, Naka T.
    J Med Chem; 2001 Jul 19; 44(15):2438-50. PubMed ID: 11448226
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.